Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Pfizer - Beyond 2020: Targeting EGFR Exon 19 and Exon 21 L858R in the New Era

Panel discussion and closing

Date

21 Nov 2020

Session

Pfizer - Beyond 2020: Targeting EGFR Exon 19 and Exon 21 L858R in the New Era

Presenters

Nellie Cheah Lay Chin

Authors

R.A. Soo1, Y. Wu2, U. Batra3, N. Cheah Lay Chin4

Author affiliations

  • 1 Department Of Haematology-oncology, National University Hospital, 119074 - Singapore/SG
  • 2 Guangdong Lung Cancer Institute, 510000 - Guangzhou/CN
  • 3 Medical Oncology, Rajiv Gandhi Cancer Institute & Research Center, 110085 - New Delhi/IN
  • 4 Loh Guan Lye Specialist Centre, 10400 - George Town/MY

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.